Design, synthesis and biological evaluation of quinazoline derivatives as anti-trypanosomatid and anti-plasmodial agents
- 1 May 2015
- journal article
- research article
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 96, 296-307
Abstract
No abstract availableKeywords
Funding Information
- PAPIIT-UNAM (IN213914)
- CONACYT-62488
- SIT/COFAA-IPN
This publication has 32 references indexed in Scilit:
- Effect of Ambient Temperature on the Clinical Manifestations of Experimental Diffuse Cutaneous Leishmaniasis in a Rodent ModelVector-Borne and Zoonotic Diseases, 2012
- AutoDock4 and AutoDockTools4: Automated docking with selective receptor flexibilityJournal of Computational Chemistry, 2009
- Activity of Hydroxyurea against Leishmania mexicanaAntimicrobial Agents and Chemotherapy, 2008
- Drug discovery and development for neglected parasitic diseasesNature Chemical Biology, 2006
- Scalable molecular dynamics with NAMDJournal of Computational Chemistry, 2005
- A pteridine reductase gene ptr1 contiguous to a P-glycoprotein confers resistance to antifolates in Trypanosoma cruzi1Note: nucleotide sequence data reported in this paper have been submitted to the GenBankTM data base with the accession number U61221.1Molecular and Biochemical Parasitology, 1997
- VMD: Visual molecular dynamicsJournal of Molecular Graphics, 1996
- Comparative Protein Modelling by Satisfaction of Spatial RestraintsJournal of Molecular Biology, 1993
- A rapid method for testing in vivo the susceptibility of different strains of Trypanosoma cruzi to active chemotherapeutic agentsMemórias do Instituto Oswaldo Cruz, 1984
- Antimalarial drugs. 24. Folate antagonists. 2. 2,4-Diamino-6-{[aralkyl and (heterocyclic)methyl]amino}quinazolines, a novel class of antimetabolites of interest in drug-resistant malaria and Chagas' diseaseJournal of Medicinal Chemistry, 1972